BloodScan Biotech Inc. is a biotechnology company dedicated to precision oncology. Founded through technology transfer from a research team at the University of Michigan, BloodScan focuses on advancing innovations in liquid biopsy with the goal of becoming a key global driver in early cancer detection and disease monitoring. Our flagship product, Labyrinth One, is the world’s only liquid biopsy system capable of achieving tissue-biopsy-comparable performance. The system enables stable, fully automated enrichment of circulating tumor cells (CTCs) and delivers ultra-sensitive capabilities for early cancer screening and monitoring. Three Core Advantages: 1. Reliable CTC Isolation and Monitoring in Advanced Cancer – Enables disease monitoring and treatment response assessment in late-stage patients. 2. Tissue-Biopsy-Comparable Performance – Provides accuracy and biological integrity comparable to conventional histopathology. 3. Ultra-Sensitive Early Cancer Screening – Enhances early cancer detection rates to support more precise and timely treatment decisions. Our vision is to establish CTCs as a central pillar of next-generation cancer diagnostics, empowering healthcare systems worldwide to deliver earlier, more precise, and more personalized cancer care. | BloodScan Biotech Inc. Pioneering Liquid Biopsy for Precision Oncology BloodScan Biotech Inc. is a biotechnology company at the forefront of next-generation liquid biopsy technologies, committed to transforming cancer diagnostics through precision medicine. Established in 2023 as a spin-off from the University of Michigan, BloodScan focuses on advancing circulating tumor cell (CTC) isolation to improve early cancer detection, real-time treatment monitoring, and personalized therapeutic decision-making. The heart of BloodScan’s innovation is the Labyrinth One – Automated CTC Enrichment System, a compact, benchtop platform designed for high-throughput, label-free isolation of viable CTCs directly from blood samples. Unlike traditional antibody-based capture technologies, Labyrinth One utilizes microfluidic separation to deliver exceptional purity, recovery, and reproducibility—all within a 15-minute workflow. This allows for seamless integration into both clinical and research laboratory settings, enabling routine use of CTCs for diagnostics and translational oncology research. BloodScan’s mission is to bridge the gap between academic innovation and clinical implementation. Through strategic partnerships with research institutes, oncology centers, and clinical laboratories, the company aims to accelerate the adoption of liquid biopsy technologies and expand access to non-invasive cancer diagnostics that can meaningfully improve patient outcomes.
Biurteksa
Biurteksa is an international trading company with offices in Europe and the Middle-East. We specialise in large volume sales of printers, docking stations, headsets, mice, webcams, monitors, audio and other IT accessories. We deal with brands including: HP, Lenovo, Logitech, Microsoft, Jabra, Poly, Dell, Kyocera, Razer and more.
Benilight
Illuminating the Future of Brain Health: Benilight at BioUSA 2026 The Vision: Beyond Light, Toward Neural Recovery In a world grappling with a growing mental health crisis, Benilight is redefining the boundaries of non-invasive therapy. We don’t just provide devices; we provide a Neural Recovery Ecosystem. At BioUSA 2026, we are proud to unveil the next evolution of our flagship technology: the iLED Pro, now integrated with an AI-powered Medical Doctor App, specifically targeting Post-Traumatic Stress Disorder (PTSD). Core Innovation: The iLED Pro & AI Synergy The iLED Pro is an FDA-listed, professional-grade photobiomodulation (PBM) device. While it has already set industry standards for pain management and tissue recovery, our focus has shifted toward the final frontier: The Brain. Triple-Wavelength Precision: Utilizing a combination of 660nm (Red), 850nm (NIR), and 940nm (NIR), the iLED Pro penetrates deep into cortical tissues to stimulate mitochondrial function and ATP production. Ethical Engineering: Our flexible LED pads are built for the rigors of clinical and home use, tested to withstand over 300,000 bends without losing intensity or integrity. The AI Doctor Integration: Our new AI-driven application acts as a digital clinician. It monitors patient progress, optimizes light dosages based on neurological biofeedback, and provides real-time data to healthcare providers, making the iLED Pro a truly “smart” medical asset. The Indication: A New Hope for PTSD Post-Traumatic Stress Disorder remains one of the most difficult conditions to treat without heavy reliance on pharmaceuticals. Benilight is currently pursuing clinical evidence and regulatory pathways for a PTSD indication, leveraging PBM’s ability to: – Reduce Neuro-inflammation: Calming the physiological “storm” associated with trauma. – Enhance Connectivity: Improving functional connectivity in brain regions impacted by TBI and PTSD. – Optimize Sleep & Circadian Rhythms: Directly addressing the insomnia and night terrors that plague PTSD survivors. Strategic Opportunities for Partners We are at BioUSA to meet the visionaries who will help us scale this life-changing technology globally. Our Value Propositions : – Participation in a high-growth Digital Health firm bridging the gap between MedTech hardware and AI software. – Exclusive access to a versatile, FDA-listed device with a massive untapped market in mental health and sports medicine. – Collaborative opportunities to integrate our LED technology into broader telehealth platforms or specialized clinical chains. Why Visit the Benilight Booth? – Live Demos: Experience the soothing, deep-penetration technology of the iLED Pro firsthand. – The AI Interface: See how our AI App transforms a light therapy device into a sophisticated diagnostic and treatment tool. – Clinical Insights: Speak with our leadership team, including CEO Yosik Song and CTO Dr. Sungkyoo Lim, who brings over 30 years of light-science expertise to the table. Meet Us in San Diego – Event: Bio International Convention (BioUSA) 2026 – Location: San Diego Convention Center – Dates: June 22 – 25, 2026 – Focus: AI-Powered Photobiomodulation for PTSD & Brain Health | Benilight has developed LED medical devices and healthcare products utilizing red LEDs and near-infrared (NIR) LEDs. Our company has conducted extensive research on the effects of LED light on the skin. These devices have been listed as Class II medical devices by the US FDA for pain relief and the enhancement of blood circulation.
Baxter
Every day, millions of patients, caregivers and healthcare providers rely on Baxter’s leading portfolio of diagnostic, critical care, kidney care, nutrition, hospital and surgical products used across patient homes, hospitals, physician offices and other sites of care. Baxter employees worldwide are building upon the company’s rich heritage of medical breakthroughs to advance the next generation of transformative healthcare innovations. Hillrom products are now part of Baxter’s global portfolio. | Baxter International Inc. through its subsidiaries, develops, manufactures and markets products that save and sustain the lives of people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma, and other chronic and acute medical conditions. | Baxter products and therapies can be found throughout hospitals and clinics – from the ER to the OR, from the pharmacy to the ICU – as well as advancing patients’ care in their homes. For 90 years, we have been at the critical intersection of saving and sustaining lives. We have pioneered significant medical innovations that changed healthcare. From the first commercially produced intravenous solutions to today’s leading acute, nutritional, renal and surgical care innovations, we are committed to providing leading healthcare solutions.
Barreleye
Barreleye is a medical AI startup developing quantitative ultrasound technology that enables accurate and non-invasive diagnostic insights. The company aims to overcome the limitations of conventional ultrasound and expand access to high-quality healthcare worldwide. | Mission: To revolutionize diagnostic accuracy and efficiency through cutting-edge medical imaging AI technology, enabling patients around the world to receive faster and more accurate healthcare services. Vision: To become a global leader in the field of medical imaging by serving as a “smart diagnostic partner” that extends the eyes and hands of healthcare professionals through AI-powered diagnostic support software (SaMD). Products: *Vis-CUS: An iOS app that analyzes cardiac ultrasound using AI to provide real-time cardiac output and heart rate measurements. *Vis-BUS: AI software that assists diagnosis by detecting abnormalities in breast ultrasound images and providing an assessment of malignancy or benign. *Int-BUS: AI-powered diagnostic support software that quantitatively determines the malignancy of breast ultrasound images. *Int-HUS: An interactive learning and evaluation system aimed at improving interpretation skills for abdominal ultrasound imaging.
Avatar Medical
Avatar Medical transforms CT and MRI scans into instant, lifelike 3D avatars for deeper clinical understanding. Its Vision platform helps physicians communicate clearly, streamline workflow, and build trust. Backed by Curie, Pasteur, Barco, and Dell, it powers the Clinic of the Future. | Founded in 2020, Avatar Medical is leading the evolution from medical imaging to medical understanding. By transforming CT and MRI scans into intuitive, lifelike 3D avatars, instantly and without segmentation. The company’s flagship product, Avatar Medical Vision, empowers physicians to communicate more effectively, improve workflow efficiency, and build trust through shared understanding. Backed by research from Institut Curie and Institut Pasteur and strengthened by a strategic partnerships with Barco and a distribution agreement with Dell, Avatar Medical is advancing the Clinic of the Future across the U.S., Europe, and Asia. Seeing is Healing.
AURZEN
Aurzen is the entertainment technology brand that brings what matters into focus. Guided by the slogan “Focus on The Good Stuff” we design products that make life’s precious moments immersive and memorable. In a world of distractions, Aurzen stands out with high-quality products that foster connection and deliver meaningful experiences.
Auckland UniServices
UniServices is the University of Auckland’s research commercialisation and growth team. We sit at the intersection of research, innovation, and industry, with a mission to grow and commercialise the University’s vast footprint of research expertise.